Singapore markets open in 3 hours 9 minutes

Emergent BioSolutions Inc. (EBS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
3.3000+1.3700 (+70.98%)
At close: 04:00PM EDT
3.2600 -0.04 (-1.21%)
After hours: 05:51PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.9300
Open2.9500
Bid3.2100 x 3100
Ask3.2200 x 1300
Day's range2.8200 - 4.7600
52-week range1.4200 - 10.8800
Volume150,696,964
Avg. volume3,089,452
Market cap172.89M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Emergent BioSolutions Reports First Quarter 2024 Financial Results

    First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of $66.9 millionUpdates FY 2024 guidance GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the first quarter ended March 31, 2024. "We delivered a strong quarter with growth across all our key products,” said Joe Papa, President and CEO at Emergent. “We also took significa

  • GlobeNewswire

    Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position

    Proactive changes aim to ensure long-term sustainability and growth, optimize operations, streamline processes, and allocate resources more efficientlyReorganization will align with evolving business goals, strategic priorities and new operational planOverall efforts expected to deliver annual cost savings of approximately $80 million GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced the next phase of its new operational plan that consolidates

  • GlobeNewswire

    Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone

    Nearly 9 in 10 Americans surveyed agree opioid overdoses are a concern for teenagers and college students; parents in the survey want life-saving treatment to be easily accessible in case of an emergency GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the results of a new national public opinion survey showing that more than 90 percent of Americans surveyed recognize opioid overdoses are a pressing concern for teenagers and college stude